2024 Speakers
Christopher Rold
Vice President, Vector Development, Analytical Development & Quality Control
Adicet Bio Inc.
Shibani Mitra-Kaushik
Head, Product Control Analytics, Cell Therapies
Takeda Pharmaceutical Co. Ltd.
What Our Speakers Had to Say
“ I am excited to contribute my expertise in potency assay development for an allogenic, stem-cell derived cell therapy, a unique area that is often underrepresented in the cell therapy space. I would like to learn about others in this field and what challenges they encountered in developing/executing their strategy.”"
Shapnil Bhuiyan, Research Scientist, Vertex Pharmaceuticals
